Literature DB >> 26492280

Progress Toward Poliomyelitis Eradication--Afghanistan, January 2014‒August 2015.

Chukwuma Mbaeyi, Akif Saatcioglu, Rudolf H Tangermann, Stephen Hadler, Derek Ehrhardt.   

Abstract

Despite recent progress toward global polio eradication, endemic transmission of wild poliovirus (WPV) continues to be reported in Afghanistan and Pakistan. The Afghanistan program must overcome many challenges to remain on track toward achieving the objectives set in the 2013–2018 strategic plan of the Global Polio Eradication Initiative (GPEI). Cross-border transmission of WPV type 1 (WPV1) continues to occur among children traveling to and from Pakistan. The country's routine immunization system remains weak and unable to reach recommended benchmarks in most regions; hence, the national Polio Eradication Initiative (PEI) relies mainly on providing children aged <5 years with oral poliovirus vaccine (OPV), administered during supplementary immunization activities (SIAs). Because of ongoing conflict and insecurity, some children continue to be missed during SIAs in areas not under government control; however, the majority of missed children live in accessible areas and are often unreached because of a failure to plan, implement, and supervise SIAs efficiently. This report describes polio eradication activities and progress in Afghanistan during January 2014‒August 2015 and updates previous reports. During 2014, a total of 28 WPV1 cases were reported in Afghanistan, compared with 14 cases in 2013; nine cases were reported during January‒August 2015, the same number as during the same period in 2014. To eliminate poliovirus transmission in Afghanistan, emergency operations centers (EOCs) need to be established at the national level and in critical regions without delay to improve overall coordination and oversight of polio eradication activities. The recently revised National Emergency Action Plan for polio eradication needs to be fully implemented, including detailed microplanning and enhanced monitoring and supervision of SIAs, as well as improved cross-border coordination with Pakistan.

Entities:  

Mesh:

Year:  2015        PMID: 26492280     DOI: 10.15585/mmwr.mm6441a2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  6 in total

1.  Seroprevalence of poliovirus antibodies in the Kansas City metropolitan area, 2012-2013.

Authors:  Gregory S Wallace; Barbara A Pahud; William C Weldon; Aaron T Curns; M Steven Oberste; Christopher J Harrison
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

2.  Seroprevalence of Poliovirus Antibodies in the United States Population, 2009-2010.

Authors:  Gregory S Wallace; Aaron T Curns; William C Weldon; M Steven Oberste
Journal:  BMC Public Health       Date:  2016-08-05       Impact factor: 3.295

3.  Progress Toward Poliomyelitis Eradication - Afghanistan, January 2016-June 2017.

Authors:  Maureen Martinez; Hemant Shukla; Joanna Nikulin; Mufti Zubair Wadood; Stephen Hadler; Chukwuma Mbaeyi; Rudolph Tangermann; Jaume Jorba; Derek Ehrhardt
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-08-18       Impact factor: 17.586

4.  Routine Immunization Service Delivery Through the Basic Package of Health Services Program in Afghanistan: Gaps, Challenges, and Opportunities.

Authors:  Chukwuma Mbaeyi; Noor Shah Kamawal; Kimberly A Porter; Adam Khan Azizi; Iftekhar Sadaat; Stephen Hadler; Derek Ehrhardt
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

5.  Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria.

Authors:  Zubairu Iliyasu; Harish Verma; Kehinde T Craig; Eric Nwaze; Amina Ahmad-Shehu; Binta Wudil Jibir; Garba Dayyabu Gwarzo; Auwalu U Gajida; William C Weldon; M Steven Oberste; Marina Takane; Pascal Mkanda; Ado J G Muhammad; Roland W Sutter
Journal:  Vaccine       Date:  2016-08-31       Impact factor: 3.641

Review 6.  Arbovirosis and potential transmission blocking vaccines.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Tonya M Colpitts
Journal:  Parasit Vectors       Date:  2016-09-23       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.